NCT06232746View on ClinicalTrials.gov

"Magnetic Jejuno-Ileal Diversion Study (MJI Study)"

NAActive, not recruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

February 13, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2025

Conditions
ObesityType 2 Diabetes
Interventions
DEVICE

Magnet System, DI Biofragmentable

Anastomoses achieved by magnetic compression.

Trial Locations (1)

130 00

OB KLINIKA a.s., Prague

Sponsors
All Listed Sponsors
lead

GT Metabolic Solutions, Inc.

INDUSTRY

NCT06232746 - "Magnetic Jejuno-Ileal Diversion Study (MJI Study)" | Biotech Hunter | Biotech Hunter